Perrigo Company PRGO Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Infant Formula | $89.7M— | —— | —— | —— | $87.8M— | |
| Self Care | $543.3M— | —— | —— | —— | $614.3M— | |
| Specialty Care | $207M— | —— | —— | —— | $199.1M— | |
| Net Sales by Product | ||||||
| Digestive Health | $96.6M-27.9% | $134M+15.4% | $116.1M-2.9% | $119.6M+5.9% | $112.9M-22.2% | |
| Healthy Lifestyle | $142.7M-2.4% | $146.2M+12.2% | $130.3M-3.1% | $134.4M-14.4% | $157M+15.4% | |
| Pain & Sleep | $106.6M— | —— | —— | —— | $129.7M— | |
| Skin Health | $151.9M— | —— | —— | —— | $149.6M— | |
| Upper Respiratory | $197.4M-9.4% | $217.8M+3.8% | $209.8M+17.4% | $178.7M-16.8% | $214.7M+4.0% | |
| Women's Health | $55.1M-8.0% | $59.9M+22.5% | $48.9M-18.2% | $59.8M+20.8% | $49.5M-2.4% | |
| Net Sales by Geography | ||||||
| All other countries | $23.4M-12.0% | $26.6M+10.8% | $24M+1.3% | $23.7M+6.3% | $22.3M-17.4% | |
| Europe | $391.4M-1.8% | $398.4M+3.8% | $384M-8.9% | $421.7M+2.3% | $412.3M+8.8% | |
| Ireland | $4.1M-67.7% | $12.7M+47.7% | $8.6M-12.2% | $9.8M-10.9% | $11M-14.1% | |
| U.S. | $554.4M-19.0% | $684.6M+7.8% | $635.3M+4.0% | $610.9M+0.3% | $609.3M-16.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Perrigo Company break its business down?
- Perrigo Company (PRGO) reports net sales by business across 3 parts — Infant Formula, Self Care and Specialty Care. Each is extracted from the segment footnotes and tracked over time.
- Where does Perrigo Company's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Perrigo Company's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
